natgillin/translations-raw huggingface dataset:
PA for detailed list of treatment only (categories not specified) 6 
Predhodna odobritev samo za podrobni seznam zdravljenj (kategorije niso navedene) 6
Article 8(7) of the Directive requires Member States to ‘make publicly available which healthcare is subject to prior authorisation'. 
Člen 8(7) Direktive določa, da morajo države članice „javno objavi[ti], za katero zdravstveno varstvo je potrebna predhodna odobritev".
Use of prior authorisation 
Uporaba predhodne odobritve
Some Member States provide links to different legal documents; others give a general description of quality assurance strategies; a few provide detailed information (including links to hospital evaluation systems featuring typical safety parameters, e.g. mortality rate, number of cases treated with complications); others direct citizens to specific sources - websites or a named person. 
Nekatere države članice zagotavljajo povezave do različnih pravnih dokumentov; druge na splošno opišejo strategije za zagotavljanje kakovosti; nekaj jih zagotovi podrobne informacije (vključno s povezavami do sistemov ocenjevanja bolnišnic z značilnimi parametri varnosti, npr. umrljivost, število primerov zdravljenja s komplikacijami); druge usmerjajo državljane v posebne vire, in sicer na spletne strani ali imenovano osebo.
For example, some Member States reimburse or provide consultations with general practitioners at a distance, whilst others do not. 
Nekatere države članice na primer povrnejo stroške za posvetovanja s splošnimi zdravniki na daljavo ali taka posvetovanja zagotovijo, druge pa ne.
But the Directive does provide a ready-made space (and forum, in the shape of the network of NCPs, which meets regularly) for the Commission and Member States to share ideas on how this challenge might be met. 
Ampak Direktiva zagotavlja vnaprej pripravljen prostor (in forum v obliki mreže nacionalnih kontaktnih točk, ki se redno srečuje) za izmenjavo idej med Komisijo in državami članicami o načinih reševanja tega izziva.
As of 1 July 2015, four infringement proceedings remained open, and all four Member States concerned had made firm commitments to address the outstanding issues. 
Od 1. julija 2015 so odprti še štirje postopki za ugotavljanje kršitev, vse zadevne države članice pa so se trdno zavezale, da bodo obravnavale nerešena vprašanja.
The Commission is working with healthcare providers and authorities to raise awareness of the possibilities offered by ERNs, and to gather support for potential networks or members of networks. 
Komisija sodeluje z izvajalci in organi zdravstvenega varstva, da bi okrepila ozaveščenost o možnostih, ki jih zagotavljajo evropske referenčne mreže, in pridobila podporo za morebitne mreže ali člane mrež.
In these 14 Member States, therefore, it is unclear for patients exactly which treatments are subject to prior authorisation, since the use of at least one of these criteria - and sometimes both - has not been elucidated by national authorities. 
V teh 14 državah članicah torej pacienti ne vedo, za točno katere oblike zdravljenja velja predhodna odobritev, saj nacionalni organi niso pojasnili uporabe vsaj enega od teh meril, v nekaterih primerih pa celo obeh.
Interviews with 20 health insurers as part of an evaluative study​[2]​ on behalf of the Commission found that 15 of them thought that patients in their country do not know whether a treatment is subject to prior authorisation or not, and that patients therefore tended to request prior authorisations even when this was not necessary. 
Na podlagi razgovorov z 20 zdravstvenimi zavarovalnicami v okviru evalvacijske študije​[2]​, ki je bil izvedena v imenu Komisije, je bilo ugotovljeno, da jih 15 meni, da pacienti v njihovi državi ne vedo, ali za zdravljenje velja predhodna odobritev ali ne, in da jo zato običajno zahtevajo, tudi če ni potrebna.
It may be that that the natural demand for cross-border healthcare is relatively low for a number of reasons: unwillingness of patients to travel (e.g. because of proximity to family or familiarity with home system); language barriers; price differentials between Member States; acceptable waiting times for treatment in the Member State of affiliation. 
Morda je naravno povpraševanje po čezmejnem zdravstvenem varstvu sorazmerno nizko iz več razlogov: nepripravljenost pacientov, da bi potovali (npr. zaradi bližine družine ali poznavanja domačega sistema); jezikovne ovire; razlike v ceni med državami članicami; sprejemljive čakalne dobe za zdravljenje v državi članici zdravstvenega zavarovanja.
Of nine NCPs surveyed, three had fewer than 10 requests for information per month, four had between 10 and 100 requests, and only two had more than 100 requests per month. 
Od devetih nacionalnih kontaktnih točk, ki so bile proučene, so tri imele manj kot 10 zahtevkov za informacije na mesec, štiri so imele med 10 in 100 zahtevki, samo dve pa sta imeli več kot 100 zahtevkov na mesec.
Two Member States (Poland and Greece) reported that they had neither authorised nor refused any requests for prior authorisation in 2014 and two (Croatia and Portugal) received just one each. 
Dve državi članici (Poljska in Grčija) sta sporočili, da leta 2014 nista niti odobrili niti zavrnili nobenih zahtevkov za predhodno odobritev, dve (Hrvaška in Portugalska) pa sta vsaka prejeli samo po eno.
Thirdly, whilst some Member States have implemented the Directive fully and are making considerable efforts to facilitate patients' rights to cross-border healthcare, there are a considerable number of Member States where the obstacles placed in the way of patients by health systems are significant, and which, in some cases at least, appear to be the result of intentional political choices: some of the current systems of prior authorisation are more extensive than the current numbers of requests would appear to justify; in many cases it is not clear exactly which treatments require prior authorisation; lower reimbursement tariffs than those used in the home Member State are a clear disincentive; there are a number of burdensome administrative requirements which may well deter patients. 
Tretjič, medtem ko so nekatere države članice v celoti izvedle Direktivo in si precej prizadevajo, da bi spodbujale pravice pacientov do čezmejnega zdravstvenega varstva, se pacienti v znatnem številu držav srečujejo z velikimi ovirami zdravstvenih sistemov, ki se vsaj v nekaterih primerih zdijo rezultat namernih političnih izbir: nekateri trenutni sistemi predhodne odobritve so obširnejši, kot pa je glede na trenutno število zahtevkov mogoče ustrezno utemeljiti; v mnogih primerih ni jasno, za natanko katera zdravljenja je potrebna predhodna odobritev; nižje tarife za povračilo stroškov kot tiste, ki se uporabljajo v matični državi članici, so nedvomno odvračilne; obstaja več obremenjujočih upravnih zahtev, ki morda odvračajo paciente.
Ten Member States recorded more than 1 000 information requests. 
Deset držav članic je zabeležilo več kot 1 000 zahtevkov za informacije.
Patient mobility for planned healthcare - under both the Directive and the Social Security Regulations - remains low, whilst patient mobility in terms of unplanned healthcare seems to be considerably higher. 
Mobilnost pacientov pri načrtovanem zdravstvenem varstvu - v okviru Direktive in uredb o socialni varnosti - je še vedno majhna, mobilnost pacientov v smislu nenačrtovanega zdravstvenega varstva pa se zdi precej večja.
Subjective, opinion-based data was also collected in the focus countries and at European level via 59 stakeholder interviews and an online survey addressed to the 12 NCPs in the focus countries. 
Zbrani so bili tudi subjektivni in na mnenju temelječi podatki v državah v žarišču ter na evropski ravni v okviru razgovorov z 59 deležniki in spletne ankete, ki je bila usmerjena v 12 nacionalnih kontaktnih točk v državah v žarišču.
It is questionable whether this is in line with the criterion in Article 8(2)(a), which relates to the way treatment is provided in the Member State of affiliation rather than the Member State of treatment. 
Vprašljivo je, ali je to v skladu z merilom iz člena 8(2)(a), ki je povezan s tem, kako se zagotovi zdravljenje v državi članici zdravstvenega zavarovanja in ne v državi članici zdravljenja.
It is also likely that requests relating to cross-border healthcare outside the scope of Directive 2011/24/EU have sometimes been included, e.g. questions relating to the European Health Insurance Card (EHIC) etc. 
Verjetno so bili v nekatere primere zajeti tudi zahtevki v zvezi s čezmejnim zdravstvenim varstvom, ki ne sodijo na področje uporabe Direktive 2011/24/EU, npr. vprašanja glede evropske kartice zdravstvenega zavarovanja itd.
It was due to be transposed by Member States by 25 October 2013. 
Države članice so jo morale prenesti v nacionalno zakonodajo do 25. oktobra 2013.
Twenty-one Member States have introduced a system of prior authorisation (Austria, the Czech Republic, Estonia, Finland, Lithuania, the Netherlands and Sweden have not, although some of these have introduced legislation enabling them to introduce such a system at a later date, should they so wish). 
Sistem predhodne odobritve je uvedlo 21 držav članic (Avstrija, Češka, Estonija, Finska, Litva, Nizozemska in Švedska niso, čeprav so nekatere od teh uvedle zakonodajo, ki jim omogoča uvedbo takega sistema pozneje, če bodo to želele).
Article 11 of Directive 2011/24/EU concerns mutual recognition of prescriptions between Member States. 
Člen 11 Direktive 2011/24/EU zadeva vzajemno priznavanje receptov med državami članicami.
At the other end of the spectrum, Italy received 177 (103 authorised) and Slovakia 139 (121 authorised). 
Nasprotno pa je Italija prejela 177 (103 odobrenih) zahtevkov, Slovaška pa 139 (121 odobrenih).
A detailed breakdown of data may be found in Annex A, which also sets out various qualifications regarding the data collection exercise, not least that the Directive was implemented at different times in different Member States and data may not therefore cover all of 2014). 
Podrobna razčlenitev podatkov je na voljo v Prilogi A, kjer so navedene tudi različne omejitve v zvezi z zbiranjem podatkov, tudi to, da je bila Direktiva v različnih državah članicah prenesena v različnih časovnih obdobjih, zato morda niso bili na voljo podatki za celo leto 2014.
Any system of prior authorisation must be necessary and proportionate to the objective to be achieved, and may not constitute a means of arbitrary discrimination or an unjustified obstacle to the free movement of patients. 
Vsak sistem predhodne odobritve mora biti nujen in sorazmeren z zadanim ciljem ter ne sme predstavljati sredstva za samovoljno diskriminacijo ali neutemeljene ovire za prosti pretok pacientov.
The ‘pseudo-patient' research method was used to take account of the ‘end-user' perspective. 
Uporabljena je bila raziskovalna metoda z nepravimi pacienti, da bi se upošteval vidik končnega uporabnika.
This generally low volume of patient mobility for planned healthcare appears to be equally the case for care under the Social Security Regulations. 
Zdi se, da ta na splošno majhen obseg mobilnosti pacientov za načrtovano zdravstveno varstvo velja tudi za oskrbo v okviru uredb o socialni varnosti.
The Commission has since begun the process of establishing ERNs, including the establishment of the Board of Member States, which will be charged with approving proposals for ERNs. 
Od takrat je Komisija začela proces ustanavljanja evropskih referenčnih mrež, vključno z ustanavljanjem odbora držav članic, ki bo zadolžen za odobritev predlogov za evropske referenčne mreže.
Several Member States require prior authorisation if the healthcare requires an overnight stay in the Member State of treatment. 
Več držav članic zahteva predhodno odobritev, če zdravstveno varstvo zahteva prenočitev v državi članici zdravljenja.
Of the 21 Member States who introduced a system of prior authorisation, 17 were able to supply data on numbers of requests for authorisation specifically under the Directive. 
Od 21 držav članic, ki so uvedle sistem predhodne odobritve, jih je 17 lahko zagotovilo podatke o številu zahtevkov za odobritev izrecno v okviru Direktive.
Of these 23, Finland, France and Luxembourg provided aggregate data for the Directive and the Social Security Regulations. 
Od teh 23 držav so Finska, Francija in Luksemburg zagotovili skupne podatke v okviru Direktive in uredb za socialno varnost.
Nine of the 14 Member States have set out which treatments they consider to meet the ‘highly specialised' criterion, whilst five have not. 
Devet od 14 držav članic je opredelilo, katere oblike zdravljenja naj bi ustrezale merilu „visoka specializiranost", pet pa ne.
The evaluation study cited above indicates considerable variation in the performance of National Contact Points in this regard. 
Že navedena evalvacijska študija glede tega kaže precejšnje razlike v učinkovitosti nacionalnih kontaktnih točk.
The Commission adopted Implementing Decision 2011/890/EU concerning the eHealth Network on 22 December 2011.​[11]​. 
Komisija je 22. decembra 2011 sprejela Izvedbeni sklep 2011/890/EU o mreži e-zdravja​[11]​.
There may well be merit in exploring common approaches or guidelines for the work of NCPs in future discussions. 
Morda bi v prihodnjih razpravah bilo dobro proučiti skupne pristope ali smernice za delo nacionalnih kontaktnih točk.
Of the 26 Member States who responded, all but Luxembourg and Sweden were able to provide data on the total number of unique requests. 
Med 26 državami članicami, ki so se odzvale, sta samo Luksemburg in Švedska lahko zagotovila podatke o skupnem številu enkratnih zahtevkov.
Some Member States were able to divide their information requests by medium. 
Nekatere države članice so lahko razčlenile svoje zahtevke za informacije glede na medij.
Article 12 of the Directive requires the Commission to support the development of European Reference Networks (ERNs) of healthcare providers and centres of expertise (in particular in the area of rare diseases) by: adopting the criteria and conditions that such Networks, and providers wishing to join Networks, must fulfil; developing criteria for establishing and evaluating such Networks; and facilitating the exchange of information and expertise on the Networks. 
Člen 12 Direktive določa, da mora Komisija podpirati razvoj evropskih referenčnih mrež izvajalcev zdravstvenega varstva in strokovnih centrov (zlasti na področju redkih bolezni), tako da sprejme merila in pogoje, ki jih morajo izpolniti take mreže in izvajalci, ki se želijo pridružiti mrežam; oblikuje merila za ustanavljanje in vrednotenje takih mrež; ter olajšuje izmenjave informacij in strokovnega znanja o mrežah.
Only three had average processing times of 30 days or more: Hungary (30 days); Cyprus (40); and Slovenia (69). 
Samo v treh je obravnava povprečno trajala 30 dni ali več, in sicer na Madžarskem 30 dni, Cipru 40 dni in v Sloveniji 69 dni.
Article 7(9) permits Member States to limit the application of the rules on reimbursement of cross-border healthcare for overriding reasons of general interest. 
Države članice lahko v skladu s členom 7(9) omejijo uporabo pravil o povračilu stroškov čezmejnega zdravstvenega varstva na podlagi prevladujočih razlogov v splošnem interesu.
Of these 21, Latvia and Malta did not provide data returns. 
Od teh 21 držav Latvija in Malta nista zagotovili podatkov.
The data in Annex A shows that some Member States with prior authorisation systems have received no requests for authorisation at all (and many others have received very few). 
Iz podatkov v Prilogi A je razvidno, da nekatere države članice s sistemi predhodne odobritve niso prejele nobenega zahtevka za odobritev (mnoge druge pa so jih prejele zelo malo).
This data is from the evaluative study, which also indicated significant variation in the activity of the NCPs. 
Ti podatki izhajajo iz evalvacijske študije, ki je pokazala tudi precejšnje razlike v dejavnosti nacionalnih kontaktnih točk.
There are also differences in the communication channels used by NCPs, as the following table (covering all 28 Member States and the separate contact points for England, Scotland, Wales, Northern Ireland, and Gibraltar)​[6]​ shows. 
Obstajajo tudi razlike v komunikacijskih poteh, ki jih uporabljajo nacionalne kontaktne točke, kot je razvidno iz naslednje tabele (v katero je zajetih vseh 28 držav članic ter ločene kontaktne točke za Anglijo, Škotsko, Wales, Severno Irsko in Gibraltar)​[6]​.
The data returns made by Member States, in general, do not suggest that extensive systems of prior authorisation are justified: the numbers of people applying for authorisation are simply too small. 
Iz podatkov, ki so jih poslale države članice, na splošno ni razvidno, da so obsežni sistemi predhodne odobritve ustrezno utemeljeni: število ljudi, ki zaprosijo za predhodno odobritev, je preprosto premajhno.
^8 Commission Implementing Directive 2012/52/EU of 20 December 2012 laying down measures to facilitate the recognition of medical prescriptions issued in another Member State (OJ L 356, 22.12.2012, p. 68). 
^8 Izvedbena Direktiva Komisije 2012/52/EU z dne 20. decembra 2012 o določitvi ukrepov za olajšanje priznavanja zdravniških receptov, predpisanih v drugi državi članici (UL L 356, 22.12.2012, str. 68).
2.3 Patient flows 
2.3 Pretoki pacientov
The transposition deadline for the Directive was 25 October 2013. 
Rok za prenos Direktive je bil 25. oktober 2013.
The HTA strategy adopted by the HTA Network has demonstrated the interest in joint work by the Member States but has also shown the need for permanent and well-founded arrangements. 
Strategija za ocenjevanje zdravstvene tehnologije, ki jo je sprejela mreža za ocenjevanje zdravstvene tehnologije, je pokazala zanimanje za skupno delo držav članic ter potrebo po trajnih in dobro utemeljenih ureditvah.
They have identified NCPs as having a crucial role in the success or failure of the Directive, recommending that NCPs could provide ‘checklists' for individuals considering planned care abroad, and more detailed individual timelines of procedures, costs and reimbursement rates. 
Te organizacije so opredelile, da so nacionalne kontaktne točke bistvenega pomena pri tem, ali se bo Direktiva uspešno izvajala ali ne, pri čemer so priporočale, da bi nacionalne kontaktne točke lahko zagotovile „kontrolne sezname" za posameznike, ki razmišljajo o načrtovani oskrbi v tujini, in podrobnejše posamezne časovne načrte postopkov, stroškov in stopenj povračil stroškov.
4.3 eHealth 
4.3 E-zdravje
Initial work by the Commission shows that there is a limited number of existing cross-border projects which may provide valuable ‘lessons learned' for future parties. 
Iz začetnega dela Komisije je razvidno, da je število obstoječih čezmejnih projektov, ki bi lahko zagotovili dragocene izkušnje za prihodnje udeležene strani, omejeno.
Fourteen Member States made fewer than 100 reimbursements, of which six (Austria, Bulgaria, Cyprus, Estonia, Greece, and Portugal) recorded no reimbursements under the Directive. 
Štirinajst držav članic je izvedlo manj kot 100 povračil stroškov, od teh jih šest (Avstrija, Bolgarija, Ciper, Estonija, Grčija in Portugalska) ni zabeležilo nobenega povračila stroškov v okviru Direktive.
Some NCPs are based in the Ministry of Health, others in the healthcare insurer, and others in independent bodies. 
Nekatere nacionalne kontaktne točke imajo sedež na ministrstvu za zdravje, druge na zdravstvenih zavarovalnicah ali neodvisnih organih.
In total, only four of these Member States reported more than 1 000 reimbursements. 
Skupno so samo štiri od teh držav članic poročale o več kot 1 000 povračilih stroškov.
Since its inception, the eHealth Network has adopted guidelines on patient summaries data sets and on ePrescriptions, and position papers on: electronic identification, interoperability, the proposed Regulation on data protection; and eHealth investment to be supported by the Connecting Europe Facility (CEF). 
Mreža e-zdravja je ob ustanovitvi sprejela smernice o zbirki povzetkov podatkov o pacientih in smernice o e-receptih ter dokumente o stališčih glede elektronske identifikacije, interoperabilnosti, predlagane uredbe o varstvu podatkov ter naložbe v e-zdravje, kar bo podprto z instrumentom za povezovanje Evrope.
It clarifies the rights of patients to seek reimbursement for healthcare received in another Member State. 
Direktiva pojasnjuje pravice pacientov do povračila stroškov za zdravstveno varstvo, ki so ga prejeli v drugi državi članici.
The Network adopted a Strategy for EU cooperation on HTA in October 2014, and a reflection paper on reuse of joint HTA work in national activities in April 2015.​[15]​ 
Mreža je oktobra 2014 sprejela strategijo za sodelovanje EU pri ocenjevanju zdravstvene tehnologije, aprila 2015 pa dokument za razmislek o ponovni uporabi skupnega dela v zvezi z ocenjevanjem zdravstvene tehnologije v nacionalnih dejavnostih​[15]​.
Article 11(5) empowers the Commission to adopt, by means of delegated acts, measures to exclude specific categories of medicinal products or medical devices from the recognition of prescriptions, where necessary to safeguard public health. 
Člen 11(5) pooblašča Komisijo, da z delegiranimi akti sprejme ukrepe za izključitev posebnih kategorij zdravil ali medicinskih pripomočkov iz obsega priznavanja receptov, kadar je to potrebno zaradi varovanja javnega zdravja.
At the other end of the scale, 14 Member States had made fewer than 100 reimbursements (of which six had made no reimbursements at all). 
Na drugi strani lestvice pa je 14 držav članic, ki so izvedle manj kot 100 povračil stroškov (od tega jih šest ni izvedlo nobenega).
However, Article 7(11) requires that such limitations be necessary and proportionate, and do not constitute a means of arbitrary discrimination or an unjustified obstacle to free movement. 
Člen 7(11) pa določa, da morajo biti take omejitve nujne in sorazmerne ter da ne bi smele predstavljati sredstva za samovoljno diskriminacijo ali neutemeljene ovire za prosti pretok.
At least three Member States have adopted reimbursement practices for cross-border healthcare whereby the reimbursement tariff for patients is based on the costs that would be borne by the Member State of affiliation for care received from a private or non-contracted provider (which is considerably lower than the rate for public or contracted providers) had this healthcare been provided in its territory. 
Vsaj tri države članice so sprejele prakse povračila stroškov čezmejnega zdravstvenega varstva, pri katerih tarifa povračila stroškov za paciente temelji na stroških, ki bi jih krila država članica zdravstvenega zavarovanja za oskrbo, ki jo zagotovi zasebni ali nepogodbeni izvajalec (ti pa so znatno nižji kot stopnja, ki jo krijejo javni ali pogodbeni izvajalci), če bi bilo zdravstveno varstvo zagotovljeno na njenem ozemlju.
Articles 8(2)(b) and (c) also allow them to require prior authorisation for treatments presenting a particular risk to patients or the population or for care provided by a healthcare provider that gives rise to serious concerns relating to the quality and safety of care. 
V skladu s členom 8(2)(b) in (c) lahko tudi zahtevajo predhodno odobritev za oblike zdravljenja, ki pomenijo posebno tveganje za pacienta ali prebivalce, ali za oskrbo, ki jo zagotovi izvajalec zdravstvenega varstva in bi lahko pomenila resne pomisleke glede kakovosti ali varnosti oskrbe.
Of these, four had an average of fewer than 20 days (Denmark, Hungary, Luxembourg, and the UK) and three had average times of more than 80 days: Finland (82); Slovakia (84.3) and Sweden (150) (NB the Finnish figure relates to both the Regulations and the Directive).​[18]​ 
V štirih od teh je obravnava povprečno trajala manj kot 20 dni (Danska, Madžarska, Luksemburg in Združeno kraljestvo), v treh pa več kot 80 dni, in sicer na Finskem 82 dni, Slovaškem 84,3 dni in Švedskem 150 dni (opomba: finski podatek se nanaša na uredbi in Direktivo)​[18]​.